Evidence indicates that using recombinant adeno-associated virus AAV9 in combination with a TGF-β/Smad inhibitor can effectively mitigate silicosis-induced PF through ferroptosis inhibition [111]. This evidence concerns the gene TGFB1 and pemphigus foliaceus.